Stratatech Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 55
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $26M
Latest Deal Amount
  • Investors
  • 1

Stratatech General Information

Description

Developer of a genetically engineered human skin substitute intended to prevent skin wounds. The company's substitute is made of human cells that act as a temporary wound cover, fighting bacterial infections and promoting healing by a patient's own cells, enabling patients to get easy care from chronic, non-healing wounds easily.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 510 Charmany Drive
  • Suite 150
  • Madison, WI 53719
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stratatech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Grant 15-Oct-2018 $26M Completed Generating Revenue
16. Merger/Acquisition 01-Aug-2016 00000 00.000 00000 Completed Generating Revenue
15. Grant 31-Jul-2013 000.00 00.000 Completed Generating Revenue
14. Angel (individual) 01-Jan-2012 000 00.000 Completed Generating Revenue
13. Grant 31-Oct-2011 00.00 00.000 Completed Generating Revenue
12. Later Stage VC 01-Jan-2011 000 00.000 Completed Generating Revenue
11. Accelerator/Incubator 01-Jan-2011 00.000 Completed Generating Revenue
10. Grant 17-Nov-2010 00.00 00.000 Completed Generating Revenue
9. Grant 01-Oct-2009 $1.7M $1.13M Completed Generating Revenue
8. Grant 25-Feb-2009 $500K $1.13M Completed Generating Revenue
To view Stratatech’s complete valuation and funding history, request access »

Stratatech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a genetically engineered human skin substitute intended to prevent skin wounds. The company's substitute is
Other Healthcare Technology Systems
Madison, WI
55 As of 2016
00.000
0000000000

00000000

e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Baltimore, MD
0 As of 0000
00.00
0000000000 0 00.00

000000 0

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
0000000000000
Marietta, GA
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stratatech Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gemstone Biotherapeutics Venture Capital-Backed Baltimore, MD 0 00.00 0000000000 0 00.00
000000 0000000 Accelerator/Incubator Backed Marietta, GA 000000000000
00000000 Venture Capital-Backed Birkerød, Denmark 00 0000 0000000 0000 0000
0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 000.00 0000000000 000.00
0000000 Venture Capital-Backed New York, NY 00 000.00 0000000000 0 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Stratatech Executive Team (6)

Name Title Board Seat Contact Info
Lynn Allen-Hoffmann Ph.D Founder, Chief Executive Officer, Chief Scientific Officer & Chairman
Cindy Ballweg Director, Finance & Administration and Treasurer
Allen Conner Ph.D Director, Research & Development
You’re viewing 3 of 6 executive team members. Get the full list »

Stratatech Board Members (5)

Name Representing Role Since
Benjamin Montgomery Self Board Member 000 0000
Lynn Allen-Hoffmann Ph.D Stratatech Founder, Chief Executive Officer, Chief Scientific Officer & Chairman 000 0000
Michael Hoffmann Ph.D Stratatech Board Member 000 0000
Peter Tong Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Stratatech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stratatech Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
Wisconsin Economic Development Corporation Government Minority 000 0000 000000 0
Wisconsin Investment Partners Venture Capital Minority 000 0000 000000 0
To view Stratatech’s complete investors history, request access »